NRX Pharmaceuticals
NRXP
6 hedge funds and large institutions have $3.06M invested in NRX Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0.25% more ownership
Funds ownership: 1.31% → 1.56% (+0.25%)
14% less funds holding
Funds holding: 7 → 6 (-1)
41% less capital invested
Capital invested by funds: $5.22M → $3.06M (-$2.15M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
-$2.01M |
| 2 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$1.83M |
| 3 |
BCM
Bluefin Capital Management
New York
|
-$152K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MF
1
Magnetar Financial
Evanston,
Illinois
| $1.94M | – | – | – |
|
|
PMAM
2
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
| $897K | -$1.83M | -16,673 | -56% |
|
|
YCM
3
Yakira Capital Management
Westport,
Connecticut
| $172K | – | – | – |
|
|
BCM
4
Bluefin Capital Management
New York
| $40K | -$152K | -1,390 | -14% |
|
|
5
UBS Group
Zurich,
Switzerland
| $9K | -$13.1K | -120 | -59% |
|
6
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $4K | – | – | – |
|
|
RCM
7
Rivernorth Capital Management
West Palm Beach,
Florida
| – | -$2.01M | -6,770 | Closed |
|
NRXP Hedge Fund Activity: Q2 2020 in Review
6 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals (NRXP) for Q2 2020, worth a combined $3.06M — down 41% from $5.22M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NRXP and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.
The largest seller was Rivernorth Capital Management, exiting entirely with an estimated $2.01M sold.
- 6 institutional investors held NRX Pharmaceuticals (NRXP) as of Q2 2020, down from 7 in Q1 2020.
- Funds reported $3.06M of NRX Pharmaceuticals stock for Q2 2020, down 41% quarter-over-quarter.
- 0 funds opened new NRX Pharmaceuticals positions in Q2 2020 and 1 closed out, a net change of -1 holder.
- The largest NRX Pharmaceuticals seller in Q2 2020 was Rivernorth Capital Management, an estimated $2.01M sold.
Based on aggregated 13F filings for Q2 2020.